The Future of Title 42: What You Need to Know

The Title 42 policy of the United States, a measure that has allowed the expulsion of migrants on health grounds during the pandemic, has been subject to strong criticism from migrant rights activists and human rights advocacy groups. With the increasing vaccinations and ongoing health checks, the policy is now becoming increasingly controversial.

The Title 42 was introduced in March 2020 by the Centers for Disease Control and Prevention (CDC) under the Trump administration, as a way to prevent the spread of COVID-19. It authorizes border officials to immediately expel undocumented migrants, including asylum seekers and unaccompanied minors, without any legal proceedings or access to the asylum process.

However, the policy has been criticized for violating human rights and international law. Advocates argue that it has put vulnerable migrants at risk by sending them back to dangerous and unstable situations, including countries with high levels of violence and persecution. The policy has also been criticized for disproportionately affecting black and brown migrants.

The Biden administration has faced increasing pressure to end the Title 42 policy. In May 2021, a coalition of 80 advocacy groups called on the administration to terminate the policy, arguing that it violates human rights and undermines public health efforts. In response, the Biden administration has said that it is reviewing the policy and considering changes.

The policy has also faced legal challenges. In November 2020, a federal judge ruled that the policy was likely illegal and ordered the government to stop using it to expel unaccompanied minors. However, the Biden administration has continued to use the policy, arguing that it is necessary to protect public health.

As the COVID-19 situation continues to evolve, the future of the Title 42 policy remains uncertain. While some argue that it is necessary to prevent the spread of COVID-19, others argue that it violates human rights and undermines public health efforts. The debate is likely to continue as the Biden administration reviews the policy and makes decisions on its future.